Biochemical Cardiac Risk Markers in the General Population, Hypertension and Coronary Artery Disease

Abstract

Recently there has been a growing interest in risk assessment of individuals, using biochemical markers of cardiac risk, with an increasing focus on a multi‐marker strategy. Natriuretic peptides (BNP and NT‐proBNP) are well‐established markers of increased risk in the general population and in high‐risk groups with hypertension, and coronary heart disease. However, there is at present no indication for routine measurements of natriuretic peptides in the risk assessment of individuals or patients, as there is no evidence for subsequent therapeutic initiatives. Natriuretic peptides are useful when screening for heart failure in symptomatic individuals. However, the use of NT‐proBNP screening for risk or left ventricular systolic dysfunction in the general population is still a matter of debate.